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doi:10.1016/j.ejvs.2008.10.018Abstract Background: We sought to evaluate the role of balloon angioplasty as the primary
modality in the management of vein graft stenoses.
Methods: Patients who underwent infrainguinal vein graft bypass from January 2002 to
December 2007 were enrolled into a surveillance program. Grafts which developed critical
stenoses were identified and underwent urgent angiography with a view to angioplasty of
the stenotic lesion. Lesions which were deemed unsuitable for angioplasty underwent urgent
surgical repair.
Results: Four hundred and eleven grafts were followed up for a median of 19 months (range:
2e61). Ninety-six grafts (22.6%) developed critical stenosis. Twelve grafts occluded prior to
repair and one was not intervened upon electively. Eight grafts underwent primary surgical
repair. Seventy-six grafts underwent 99 endovascular procedures. Technical success was
achieved in 60 grafts (78.9%). Of the grafts in which technical success had not been achieved,
eight underwent repeat angioplasty and three were surgically repaired. Twenty-four grafts
underwent repeat angioplasty for re-stenosis with a technical success rate of 71%. No differ-
ence was observed in graft patency (PZ 0.08) or amputation rates (PZ 0.32) between the
grafts requiring intervention to maintain patency, and grafts which did not. Smoking [OR:
2.61 (95% CI: 1.51e4.53), (PZ 0.006)], diabetes [OR: 2.55 (95% CI: 1.49e4.35), (PZ 0.006)],
renal failure [OR: 1.89 (95% CI: 1.19e3.38), (PZ 0.040)] and recurrent stenosis [OR: 3.22
(95% CI: 1.63e4.69), (P< 0.001)] were risk factors for graft occlusion.
Conclusions: Balloon angioplasty of failing infrainguinal vein bypass grafts is safe and can be
performed with an acceptable medium term patency rate, albeit with a significant risk of
re-stenosis which can be successfully treated in most patients using repeat endovascular
intervention.
ª 2008 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.-14 Hawthornbank Lane, Edinburgh, EH4 3BH, United Kingdom.
et.uk (R. Mofidi).
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Maintaining patency of infrainguinal vein bypass grafts has
been a challenging task for vascular surgeons for decades.1
These grafts are prone to the development of vein graft
stenosis, which may precipitate failure of the bypass.1e4
Features associated with the development of vein graft
stenosis are recognisable by duplex ultrasound scanning.5
Duplex scanning has been widely used for graft surveil-
lance, the rationale being that correction of stenotic
lesions is likely to improve graft patency and reduce the
risk of amputation.6e13 Considerable uncertainty still exists
about the optimal management of these threatened bypass
grafts once they are identified. Traditional operative
techniques such as patch angioplasty, interposition graft or
replacement graft remain the gold standard for the
management of vein graft stenosis. However these tech-
niques require the availability of an additional autogenous
vein and carry the risk of morbidity and mortality associ-
ated with re-operation. In addition, jump and interposition
grafts used to treat vein graft stenosis may by themselves
be at risk of development of vein graft stenosis.13 Increased
experience with the application of angioplasty in the
treatment of stenoses in other venous conduits such as
haemodialysis arterio-venous fistulae14,15 has led to the
introduction of this technique for the management of
threatened bypass grafts.16e20 However the efficacy of this
treatment modality has been questioned21 and to date no
consensus exists about its primary use in the management
of vein graft stenosis.
The aim of this study was to assess the efficacy and
safety of balloon angioplasty as the primary modality in the
management of vein graft stenoses, which are identified as
a result of duplex vein graft surveillance.
Methods
Consecutive patients, who underwent infrainguinal bypass
procedure using an autologous vein between 1st January
2002 and 31st December 2007 were studied. Infrainguinal
vein bypass grafts were performed with a variety of tech-
niques including reversed and in situ bypass grafts. The
ipsilateral long saphenous vein was the conduit of choice
for bypass. If this was found unsuitable the contralateral
long saphenous vein was used. Short saphenous and arm
veins were used in patients who had previous harvesting of
the long saphenous vein or in whom the long saphenous vein
had been found to be unusable.
Thereafter all patients were enrolled in a graft surveil-
lance program. This involved duplex scanning and the
measurement of ankle brachial index pressures before
discharge from the hospital and at 6 weeks, 3 months, 6
months, 1 year and 2 years after operation. Duplex exam-
ination was performed by two experienced vascular tech-
nologists using an Acuson Sequoia duplex ultrasound system
(Acuson, Redwood, California, USA) using a 5 MHz linear
transducer. The duplex scanning protocol during vein graft
surveillance included the assessment of inflow and outflow
vessels for quality of flow based on velocity, waveforms and
colour flow characteristics. Peak systolic velocity was
measured at the sites of stenosis, at multiple sites withinthe graft and within the outflow vessel. The velocity ratio
at the site of stenotic lesions was calculated. Any bypass
grafts with sub critical flow abnormalities found on duplex
scanning were studied more frequently at 3-month inter-
vals, whilst all grafts with critical vein graft stenosis were
referred for urgent angiography with a view to primary
endovascular treatment. Table 1 shows the duplex param-
eters used to classify vein graft stenosis and indications for
treatment.
Antegrade ipsilateral puncture was the preferred
angiographic technique. Mixtures of standard and cutting
balloon techniques were used. The size and the type of
balloon (cutting versus standard balloon) used for angio-
plasty were based on the angiographic appearance and the
site of the stenotic lesion within the vein graft. All inter-
ventions were evaluated with completion angiograms.
Technical success was defined as a less than 20% stenosis
remaining on completion angiogram (in keeping with the
PTA guideline of the Society of Cardiovascular and Inter-
ventional Radiology).22 Vascular laboratory evaluations,
including duplex scans, ankle brachial indices, were
obtained prior to discharge. Thereafter all patients re-
entered the surveillance programme at the starting point.
Patients with an unsuccessful endovascular procedure were
admitted for urgent surgical correction of vein graft
stenosis whilst those with residual stenosis were studied
more frequently: at 2 weeks, 6 weeks and then, at 3-month
intervals. This process was repeated for all patients who
developed recurrent vein graft stenosis. Postoperative
hypercholestrolemia was defined as the total cholesterol to
high density lipoprotein cholesterol (total cholesterol/HDL)
ratio of greater than 3.5. Renal failure was defined as the
Kidney Dialysis Outcomes Quality Initiative (KDOQI) chronic
kidney disease (CKD)23 stage 4 or 5 at the time of infrain-
guinal bypass surgery.
Patient demographics, type of operation, conduit and
follow up information were recorded in a computerized
database (Microsoft Access and Excel, Redmond,
Washington, USA). Data analysis was performed retrospec-
tively. Results were analysed and reported in accordance
with the reporting standards of the Society for Vascular
Surgery and the North American Chapter of the Interna-
tional Society for Cardiovascular Surgery.24 Statistical
analysis was performed using Statistical Package for Social
Sciences version 12 SPSS (SPSS, Chicago, Illinois, USA)
statistical software. Patency and limb salvage were deter-
mined using KaplaneMeier analysis. The difference in
primary assisted patency and amputation rates between
patients who underwent angiography with a view to inter-
vention for vein graft stenosis and patients who did not
develop vein graft stenosis was assessed using the log rank
test. P< 0.05 was considered significant.Results
The initial patient group of 389 patients comprised 263 men
(67.6%) and 126 women (32.4%) who underwent 411 bypass
procedures. These grafts were followed up for a median of
19 months (range: 2e61). The median (range) age of the
patients was 72 years (range: 38e87); 219 (56.3%) were
current smokers, 168 (43.2%) had diabetes and 35 (9%) had
Table 1 The velocity criteria identifying different categories of vein graft stenosis identified through duplex surveillance
(PSV: peak systolic velocity (cm/s), ABPI: ankle brachial pressure index)
PSV at the site of stenosis Post stenotic PSV Drop in ABPI
Absolute value PSV ratio
Critical stenosis (urgent treatment) >300 3.5 <40 >0.15
Mild flow disturbance (intensive surveillance) 200e300 2 >45 <0.15
Low risk grafts (standard surveillance) <200 <2 >45 <0.15
Follow up (months) 0 10 20 30 40
Grafts requiring no intervention 272 206 160 85 49
Grafts requiring intervention to
maintain patency
96 75 49 33 18
60
200 R. Mofidi et al.chronic renal failure. Three hundred and three patients
(77.9%) were on statin therapy. Ninety-eight patients (25%)
had hypercholestrolemia on follow up [median post-
operative TC/HDL ratio: 3.1 (range: 0.8e4.3)]. The indi-
cations for surgery are shown in Table 2. Three hundred and
fifty six bypasses were reversed vein grafts and 55 were in
situ vein graft bypasses. Three hundred and fifty five
bypasses (86.6%) had their origin at the femoral artery in
the groin, 16 from the external iliac artery (3.9%) and 40
bypasses (9.7%) had their proximal anastomosis from the
superficial femoral artery. The distal anastomoses were to
the above knee popliteal (132, 34%), the below knee
popliteal (148, 35%), and the tibial arteries (131, 31%).
During the follow up period, 272 grafts did not develop
significant vein graft stenosis and therefore did not require
intervention in order to maintain graft patency, whilst 96
grafts (22.6%) developed critical vein graft stenosis. A
further 43 grafts (10.4%) occluded prior to the early post-
operative (6 week) follow up scan The distribution of these
stenoses along the length of the vein graft is shown in
Fig. 1. Of these 12 grafts occluded prior to angiography and
another graft occluded following diagnostic angiography,
which revealed that the stenotic lesion identified, was not
amenable to angioplasty. One graft was found to be
stenotic for a significant proportion of its length and was
electively not intervened upon. Eight grafts underwent
open repair after diagnostic angiography, which identified
lesions not amenable to angioplasty. This was due to
inability to traverse the stenosis angiographically in three
cases, an unfavourable proximal anastomotic lesion in two
cases and external compression in a further three.
Seventy-six grafts underwent a total of 99 endovascular
procedures (Figs. 2 and 3). Median age of the grafts at the
time of the first angioplasty was 5 months (range: 7 weekse
27 months). Forty-one primary angioplasties were per-
formed with a standard balloon and 34 with a cutting
balloon. Initial technical success was achieved in 60 graftsTable 2 Indication for infrainguinal vein graft bypass in
the study population
Indication Number (%)
Intermittent claudication 39 9.5
Critical ischaemia 340 82.7
Popliteal artery
aneurysm (asymptomatic)
18 4.4
Popliteal artery
aneurysm (symptomatic)
14 3.4
Total 411 100(78.9%). Of the grafts in which initial technical success had
not been achieved, eight underwent repeat angioplasty
with good technical success and another graft was found to
have thrombosed the next day. This graft was successfully
managed with local catheter thrombolysis with good
results. Three grafts occluded prior to attempted surgical
repair and another four grafts were surgically repaired. A
total of 27 grafts (45%) developed re-stenosis of which 24
underwent a repeat attempt at angioplasty, with technical
success in 17 grafts (71%). Repeat angioplasties were per-
formed with cutting balloons. Of the grafts that had
developed re-stenosis three occluded prior to the repeat
attempt at angioplasty and a further patient was deemed
too unfit to undergo further intervention. There was no
peri-procedural mortality. Vein graft angioplasty was asso-
ciated with two puncture site haematomas both of which
were treated conservatively; in addition one patient who
had undergone cutting balloon angioplasty developed
a delayed retroperitoneal hemorrhage from a contralateral
puncture site which was managed by open surgery.Overall 30-month primary patency, primary assisted
patency and secondary patency rates were 73.2%, 82.6%
and 84.3%, respectively. No significant difference was
observed in graft patency (log rankZ 1.83, PZ 0.08) or
amputation rates (log rankZ 0.89, PZ 0.32) between the0
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Figure 1 Distribution of duplex scan-detected stenoses
identified during the surveillance program.
Figure 2 Digital subtraction angiograms of a common femoral to below knee popliteal artery bypass graft. The left image shows
a proximal graft stenosis (arrowhead), whilst the right image shows the final result after cutting balloon PTA with a 4.0-mm
diameter balloon.
Angioplasty, the Treatment for Vein Graft Stenosis 201grafts requiring intervention to maintain patency and grafts
which did not (Figs. 4 and 5). Smoking [odds ratio: 2.61 (95%
CI: 1.51e4.53), (PZ 0.006)], diabetes [odds ratio: 2.55
(95% CI: 1.49e4.35), (PZ 0.006)] and persistent hyperlip-
idemia [odds ratio: 1.89 (95% CI: 1.19e3.38), (PZ 0.04)]Figure 3 Digital subtraction angiograms of a common
femoral to above knee popliteal artery bypass graft. The left
image shows two distal anastomotic graft stenoses (arrow-
head), whilst the right image shows the final result after
cutting balloon PTA with a 3.0-mm diameter balloon.were associated with reduced graft patency whilst the need
for intervention in order to maintain graft patency was not
[odds ratio: 1.41 (95% CI: 0.79e2.60), (PZ 0.180)].
However recurrent graft stenosis was an independent risk
factor for vein graft failure [odds ratio: 3.22 (95% CI: 1.63e
4.69), (P< 0.001)] (Table 3). Similarly, continued smoking
[odds ratio: 4.03 (95% CI: 2.07e7.84), (P< 0.0001)], dia-
betes [odds ratio: 2.86 (95% CI: 1.65e4.97), (PZ 0.0002)]
and persistent hyperlipidemia [odds ratio: 2.49 (95% CI:
1.39e4.47), (PZ 0.021)] were associated with an increased
risk of amputation, whereas the need for intervention in
order to maintain graft patency was not [odds ratio: 1.24
(95% CI: 0.68e1.91), (PZ 0.32)]. Recurrent vein graft
stenosis was a risk factor for amputation of the ipsilateral
limb [odds ratio: 2.51 (95% CI: 1.41e4.32), (PZ 0.002)]
(Table 4).Follow up (months) 0 10 20 30 40
Grafts requiring no intervention 272 206 160 85 49
Grafts requiring intervention to
maintain patency
96 75 49 33 18In addition vein graft surveillance identified two pseudo-
aneurysms associated with the proximal anastomosis, which
were successfully treated with jump graft repair and three
grafts with threatened inflow, which were treated with
balloon angioplasty with successful technical results.
Discussion
The optimal treatment of a threatened vein graft bypass
has been a source of debate for several decades. The
controversy remains about the definition of a threatened
Follow up (months)
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Figure 4 KaplaneMeier plots of primary assisted patency over time in grafts which did not require intervention (black),
compared with grafts which developed a significant stenotic lesion and underwent angiography with a view to endovascular
intervention (PZ 0.08).
202 R. Mofidi et al.infrainguinal vein bypass graft and also the clinical signifi-
cance of the stenotic lesions once they are identified
through duplex vein graft surveillance.7 The authors offer
graft surveillance to all patients who have undergone
infrainguinal vein graft bypass procedures and this study
relates to the efficacy of angioplasty for the management
of these lesions rather than a discussion regarding the
efficacy of duplex vein graft surveillance.
Surgical revision of failing infrainguinal vein grafts has
been the gold standard in the management of vein graft
stenosis. Techniques of vein patch angioplasty for short
stenoses and interposition or jump graft repair for longer
lesions have been associated with excellent medium25 and
long term patency rates.26 Repair of critical vein graft
stenosis has been shown to return patency and amputation
rates of the affected vein grafts to levels approaching that
of vein grafts with no significant stenosis.13 On the other
hand surgical repair of vein graft stenosis is an invasive
procedure requiring general or regional anaesthesia in
a population of patients with significant co-morbidity. It is
also partly dependent on the availability of an appropriate
length of an additional venous conduit. In addition revised
vein grafts are themselves at risk of development of vein
graft stenosis.13,26e28 Therefore percutaneous transluminal
angioplasty, if successful, is an attractive option for the
management of vein graft stenosis.
Some years ago Berkowitz et al. reported on the results
of selective use of angioplasty for the management of vein
graft stenosis. They performed angioplasty as the primary
treatment modality in 81% of failing infrainguinal reversed
vein grafts.28 The rest were repaired by short jump grafts.They reported a 5-year primary assisted patency rate of
61%. Lesions in the proximal graft, proximal anastomosis,
and distal graft taken as a group had significantly better
patency than the mid-graft and distal anastomotic
lesions.28 Subsequent authors have reported similar results
following vein graft angioplasty.29e32 Alexander et al.
reported a significantly lower primary assisted patency
after percutaneous transluminal angioplasty (PTA) for the
treatment of vein graft stenosis, with failure rates of 31% at
6 months, 55% at 1 year, and 63% at 2 years.21 The main
reason for failure of PTA in their series was the develop-
ment of recurrent vein graft stenosis.
In this study a significant proportion of grafts, which had
undergone angioplasty with a satisfactory technical result,
developed re-stenosis, requiring secondary procedures. In
the majority of patients the secondary procedure was
endovascular with a technical success rate approaching
that of angioplasty for primary vein graft stenosis. Carlson
et al. reported their experience of PTA of infrainguinal vein
graft stenoses in 36 patients. Their initial technical success
rate was 91% and overall graft patency rate was 78% at 24
months.31 However, nine bypasses (25%) required further
attempts at angioplasty for recurrent vein graft stenosis
and seven grafts required secondary procedures.31 This
high-lights the importance of continued graft surveillance
and maintenance intervention in patients in whom
successful endovascular repair of vein graft stenosis has
been achieved. After successful treatment of vein graft
stenosis our practice was to re-enter the graft at the starting
point of vein graft surveillance. This resulted in most
re-stenoses being identified and treated in a timely manner.
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Figure 5 KaplaneMeier plots of amputation rates over time in grafts which did not require intervention (black), compared with
grafts which developed a significant stenotic lesion and underwent angiography with a view to endovascular intervention
(PZ 0.32).
Angioplasty, the Treatment for Vein Graft Stenosis 203A number of authors have reported that, notwith-
standing the higher re-stenosis rates and the need for
re-intervention, the results of endovascular treatment for
vein graft stenosis are equivalent to open surgical
repair.18,32,33 Although most of these observations were
performed in small studies with heterogenous patient
groups which were not randomized, they were potentially
subject to type II error. Avino et al. reviewed a series of
144 infrainguinal vein graft stenoses from a population of
528 grafts, which were under surveillance over a period
of 6 years.26 Seventy-seven of the failing grafts were
treated with open surgical repair and 67 were treated
using PTA. They reported similar stenosis free patency
rates of 63% for both groups26 and no significantTable 3 Factors affecting primary assisted patency after
infrainguinal bypass assessed using Cox’s multivariate
regression analysis
Variable Hazard ratio (95% CI) Significance (P)
Age 1.03 (0.62e1.36) 0.85
Gender 0.98 (0.71e1.10) 0.61
Diabetes 2.55 (1.49e4.35) 0.006
Smoking 2.6133 (1.51e4.53) 0.006
Renal failure 0.80 (0.36e1.80) 0.592
Hyperlipidemia 1.89 (1.19e3.38) 0.040
Intervention to
maintain graft
patency
1.41 (0.79e2.60) 0.18
Recurrent stenosis 3.22 (1.63e4.69) <0.001difference in patency rates between interventions for
primary versus recurrent vein graft stenoses or between
infra-genicular and supra-genicular bypasses.26 However
this has not been a universal observation; Berceli et al.
reported that open surgical revascularization imparts an
improved graft survival over endovascular interventions.
They also observed no significant difference in the
hospital length of stay or global quality of life between
the two groups.34 One might postulate these outcomes
would be potential benefits of endovascular interven-
tion.34 In this study renal failure was a risk factor for vein
graft failure.
The use of cutting balloon angioplasty is a relatively new
development for the management of vein graft stenosis.Table 4 Factors affecting amputation rates after
infrainguinal bypass assessed using Cox’s multivariate
regression analysis
Variable Hazard ratio (95% CI) Significance (P)
Age 1.12 (0.41e1.53) 0.41
Gender 0.86 (0.51e1.21) 0.52
Diabetes 2.8618 (1.65e4.97) 0.002
Smoking 4.03 (2.07e7.84) <0.001
Renal failure 0.93 (0.42e2.057) 0.852
Hyperlipidemia 2.49 (1.39e4.47) 0.021
Intervention to
maintain graft
patency
1.24 (0.68e1.91) 0.310
Recurrent stenosis 2.51 (1.41e4.32) 0.002
204 R. Mofidi et al.Engelke et al. reviewed their preliminary experience in the
use of cutting balloon PTA for the treatment of infraingui-
nal vein graft stenosis.20 They reported 18-month primary
assisted and secondary patency rates of 67% and 83%
respectively. A larger study by Garvin et al. appears to
confirm that cutting balloon angioplasty is associated with
a high technical success rate but they reported relatively
low term patency and higher complication rates. They
therefore cautioned against its widespread use for the
treatment of vein graft stenosis.35
In this study in 16 grafts (20.6%) at the time of initial
attempt at angioplasty satisfactory technical success was
not achieved. These grafts are at a significant risk of early
graft occlusion. Therefore consideration should be given to
immediate or early surgical or endovascular re-interven-
tion. Our practice was to perform duplex reassessment of
the stenotic lesion following the angioplasty attempt.
Grafts, which had a persistent severe stenosis, underwent
urgent surgical repair. Whilst grafts with intermediate
residual stenosis underwent early duplex follow up with
a repeat attempt at angioplasty if clinically indicated.
Experience with other arterialized venous conduits suggests
that immediate attempts at repeat angioplasty of venous
conduits with cutting balloons are associated with a risk of
graft rupture.36e38
Multivariate analysis offers some interesting insight into
the factors that may influence outcomes after endovascular
intervention. Not unexpectedly, smoking and diabetes were
significant risk factors for graft occlusion and amputation.
In addition hypercholestrolemia during follow up was
associated with increased risk of graft occlusion and
amputation. The authors used this as a surrogate marker of
compliance with statin therapy. Berceli et al. reported that
statin therapy was associated with improved graft dura-
bility after both endovascular and surgical revision. In
addition they found that the diagnosis of hypertension was
also associated with improved primary assisted patency
following open and endovascular intervention for vein graft
stenosis. They postulated that the reason for the latter
observation may have been related to the treatment the
patients were receiving for hypertension such as angio-
tensin converting enzyme (ACE) inhibitors or calcium
channel blockers.34 Chronic renal failure is a recognised risk
factor for vein graft failure; a recent publication by Arvela
et al. reports that the estimated glomerular filtration rate
predicts the predictor of survival, leg salvage and ampu-
tation free survival in patients with critical lower limb
ischaemia.39
Critical vein graft stenosis is a complex clinical problem.
Provided that grafts are surveyed closely, primary endo-
vascular treatment of failing infrainguinal vein grafts
appears to be safe and is associated with acceptable early
and medium term patency rates.
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